Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel.

Por Guggino, S E, Lajeunesse, D, Wagner, J A, Snyder, S H
Publicado em 1989

Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs

Por Martel-Pelletier, J, Lajeunesse, D, Reboul, P, Pelletier, J
Publicado em 2003

Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis

Por Lajeunesse, D, Martel-Pelletier, J, Fernandes, J, Laufer, S, Pelletier, J
Publicado em 2004

Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant.

Por Lajeunesse, D, Busque, L, Ménard, P, Brunette, M G, Bonny, Y
Publicado em 1996

Altered phosphorylation of Syp may be responsible for abnormal insulin-like growth factor-1 signaling in human osteoarthritic osteoblasts

Por Lajeunesse, D, Massicotte, F, Aubry, I, Martel-Pelletier, J, Pelletier, J
Publicado em 2003

Abnormal collagen type I production in osteoarthritic subchondral bone is associated with a reduced capacity of osteoblasts to mineralize in vitro

Por Aubry, I, Delalandre, A, Fernandes, JC, Martel-Pelletier, J, Pelletier, J-P, Lajeunesse, D
Publicado em 2004

Hepatocyte growth factor in osteoarthritis: when bone and cartilage decide to have a chat

Por Reboul, P, Guévremont, M, Martel-Pelletier, J, Massicotte, F, Ranger, P, Pelletier, JP, Lajeunesse, D
Publicado em 2003